Drugs / Propofol and Remifentanyl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01214057 | May 2010 → Oct 2012 | chronic rhinosinusitis | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Propofol and Remifentanyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01214057 ↗ |
| Route | Intravenous | “Remifentanil infusion will be started at a rate of 0.4 mcg/kg/min 1-2 minutes before the propofol infusion” NCT01214057 ↗ |